As coronavirus continues to spread and efforts to develop vaccines intensify, researchers are turning to flow cytometry core facilities to sort infected cells. This means biosafety has once more become a critical concern for operators in those facilities.
Samples, such as virus-infected human cells (e.g. from HIV-positive donors) or bacteria, can escape the fluidic system of a droplet-based cell sorter as aerosols and pose a potential threat to the operator. Mitigating this risk is of utmost importance for core facility operators.